United Therapeutics | Ativo Circulante



Current Assets Alterar Data
Amarin USD 573.06M 22.34M 2025-03
Ardelyx USD 356.45M 72.35M 2024-12
Baxter International USD 7.04B 1.82B 2025-03
Bayer EUR 33.75B 1.08B 2025-06
Biogen USD 7.97B 341.7M 2025-06
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Gilead Sciences USD 14.72B 2.18B 2025-06
GlaxoSmithKline GBP 17.67B 412M 2025-06
Halozyme Therapeutics USD 1.12B 139.35M 2025-06
Insmed USD 2.08B 678.89M 2025-06
Ionis Pharmaceuticals USD 2.58B 158.22M 2025-06
J&J USD 71.55B 15.66B 2025-03
Moderna USD 6.17B 595M 2025-06
Pfizer USD 43.7B 2.16B 2025-06
PTC Therapeutics USD 2.27B 43.53M 2025-06
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Sarepta Therapeutics USD 2.66B 224.45M 2025-06
Teva Pharmaceutical Industries USD 12.62B 1.09B 2025-06
United Therapeutics USD 3.83B 112.9M 2025-06
Vertex Pharmaceuticals USD 10.43B 419.1M 2025-06


United Therapeutics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.